Advances in Targeted Drug Delivery for Pain and Neurological Disorders
February 22, 2014
Houston Methodist Research Institute
Recent advances in technology and therapeutics used in the intrathecal space created a gap in education and knowledge among the neurologists, pain specialists, neurosurgeons, and physiatrists in management of patients who require targeted drug delivery for diagnostic and therapeutic purposes. The goal is to inform, educate and train physicians involved in targeted drug delivery on how to select appropriate patients for the procedures as well as teach them appropriate techniques, safety and efficacy of the proposed treatments through didactic presentations, case discussions, panel reviews and demonstrations of procedures and surgical techniques. Currently every team has their own protocols. This conference will bring together all the specialists involved in targeted drug delivery and establish common practices and systems to maintain and promote patient safety and outcomes.
This conference is designed for neurologists, neurosurgeons, pain management specialists, and physical medicine and rehabilitation specialists.
Upon completion of this course, the participant should be able to:
- Discuss the current and future trents in targeted drug delivery for the treatment of neurodegenerative disorders
- Explain the appropriate patient selection for the treatment of chronic spasticity with botulinum toxins and intrathecal baclofen
- Discuss the appropriate strategy for the treatment of patients with chronic pain syndromes through the intrathecal delivery of opioids and non-opioid therapies
- Discuss the role of botulinum toxin therapy for the treatment of chronic migraine and other painful craniofacial syndromes
- Identify the role of botulinum toxins in the treatment of focal dystonias
Didactic lectures, panel discussions, and case studies
Evaluation by online questionnaire will address program content, presentation, possible bias, and intent to change current practice.